Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications
- 1 January 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 58 (1) , 1-16
Abstract
Neurofibromatosis 1 (NF1) is a common autosomal dominant disease characterized by complex and multicellular neurofibroma tumors. Significant advancesKeywords
This publication has 172 references indexed in Scilit:
- Genetic and clinical mosaicism in a patient with neurofibromatosis type 1Human Genetics, 2003
- Inflammation and cancerNature, 2002
- NF1 Deletions in S-100 Protein-Positive and Negative Cells of Sporadic and Neurofibromatosis 1 (NF1)-Associated Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath TumorsThe American Journal of Pathology, 2001
- The Hallmarks of CancerCell, 2000
- Haploinsufficient Phenotypes inBmp4Heterozygous Null Mice and Modification by Mutations inGli3andAlx4Developmental Biology, 1997
- Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the Neurofibromatosis type 1 (NF1) tumour-suppressor geneMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- TP53 mutations are frequent in malignant NFI tumorsGenes, Chromosomes and Cancer, 1994
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Tissue culture studies of neurofibromatosis: Effects of axolemmal fragments and cyclic adenosine 3′,5′‐monophosphate analogues on proliferation of schwann‐like and fibroblast‐like neurofibroma cellsAnnals of Neurology, 1985
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971